| Filed under Company News

Company News: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

Molecular Health, Inc (MH), a company marketing computational biomedicine tools to support healthcare decisions with clinical and molecular data, and the FDA’s Center for Drug Evaluation and Research (CDER) have extended for an additional 5 years, their research collaboration to jointly address one of the biggest challenges in drug development: the prediction of drug safety.

Read more…

| Filed under Company News

Company News: Curetis Publishes Business and Financial Update for the First Nine Months of 2017

– Preparing for expected U.S. FDA clearance decision on Unyvero System and Unyvero LRT Application

– Second U.S. FDA trial initiated for Unyvero IJI Application

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today published a business and financial update for the first nine months ended September 30, 2017, and provided details on its outlook for the coming months.

Read more…

| Filed under Food for Thought

Food for Thought: Antibiotic Resistance, A Global Threat

Check out the latest video by our client Curetis for the ongoing World Antibiotic Awareness Week: